REG - Informa PLC - Informa Share Buyback Programme

InformaAnnouncement

01/03/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220301:nRSA1103Da&default-theme=true

RNS Number : 1103D  Informa PLC  01 March 2022

Informa PLC Press Release

1 March 2022

Informa Share Buyback Programme

Update on GAP II shareholder returns

Informa (LSE: INF.L), the international B2B Markets, Knowledge Services and
Business Intelligence Group today provided an update on its Share Buyback
Programme that forms part of the 2021-2024 Growth Acceleration Plan II.

Growth Acceleration Plan II ("GAP II")

GAP II is Informa's four-year programme to create a more focused, higher
growth business. This will see the Group accelerate investment in its two
businesses with scale leadership positions, B2B Markets and Academic Markets,
and divest of its Informa Intelligence portfolio of businesses.

Share Buyback Programme

Alongside investing for growth, the Group intends to return a proportion of
divestment proceeds to shareholders. Following a binding agreement for the
sale of its Pharma Intelligence business for £1.9bn on 10 February 2022, the
Group commenced a Share Buyback Programme with an initial tranche of £100m.

As part of this initial tranche, on 28 February 2022, the Company purchased
1,309,731 ordinary shares for cancellation through Merrill Lynch International
at an average price of 592.1822 pence per share.

The highest and lowest purchase price paid per share were 599.80p and 582.60p
respectively, with the aggregate details of shares purchased by trading venue
as outlined in the table below:

 Trading venue          Weighted average price paid per share (GBp)  Aggregate number of shares purchased  Lowest price paid per share  Highest price paid per share

(GBp)
(GBp)
 London Stock Exchange  593.0548                                     838,000                               583.4000                     599.6000
 Turquoise              590.0656                                     50,319                                583.2000                     599.0000
 Chi-X (CXE)            590.8630                                     335,000                               582.6000                     599.8000
 BATS (BXE)             590.0670                                     86,412                                583.0000                     599.6000

Through the period of Informa's close period (30 days from the 13 February to
14 March 2022), Merrill Lynch International will make trading decisions in
relation to the Company's securities independently of the Company. Any share
purchases during this period will be undertaken within certain pre-set
parameters and in accordance with the Company's general authority to
repurchase shares, Chapter 12 of the Listing Rules and Article 5(1)(b) of
Regulation (EU) No 596/2014 (the 'Market Abuse Regulation').

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a full
breakdown of the individual trades made as part of the buyback programme is
detailed in the attachment.

http://www.rns-pdf.londonstockexchange.com/rns/1103D_1-2022-2-28.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1103D_1-2022-2-28.pdf)

 Enquiries
 Richard Menzies-Gow, Director of IR & Communications      +44 (0) 20 8052 2787
 Heledd Hanscomb, Deputy Company Secretary                 +44 (0) 20 7017 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBKFBKCBKDCBB